Abstract:Background: The clinical challenge of differentiating suspected tuberculosis with positive T-SPOT.TB results persist. This study aims to investigate the utility of the Systemic Immune-Inflammation Index (SII), Fibrinogen, and T-SPOT.TB in distinguishing between active pulmonary tuberculosis (PTB) and non-tuberculous lung diseases. Methods: A retrospective analysis included 1,327 cases of active PTB with positive T-SPOT.TB results and 703 cases of non-tuberculous lung diseases from May 2016 to December 2020 at Meizhou People's Hospital. These were designated as the case group and the control group, respectively. The detection indicators of T-SPOT.TB: Early Secreted Antigenic Target 6 (ESAT-6), Culture Filtrate Protein 10 (CFP-10), as well as SII and Fibrinogen levels—were compared and analyzed for association and joint diagnostic value between the two groups. Results: The case group showed higher values of ESAT-6, CFP-10, SII, and Fibrinogen compared to the control group (all p < 0.001). In the case group, SII and Fibrinogen did not correlate with ESAT-6 and CFP-10 (∣rs∣ all 0.3). SII and Fibrinogen values in smear-positive pulmonary tuberculosis were higher than in smear-negative cases (all p < 0.05). The optimal diagnostic thresholds for ESAT-6, CFP-10, SII, and Fibrinogen in differentiating between active PTB and non-tuberculous lung diseases were 21.50 SFCs/10 6 PBMC, 22.50 SFCs/10 6 PBMC, 2128.32, and 5.02 g/L, respectively. Regression logistic analysis showed that ESAT-6 < 21.5 (OR: 1.637, 95% CI: 1.311–2.043, p < 0.001), CFP-10 < 22.5 (OR: 3.918, 95% CI: 3.138–4.892, p = 0.025), SII < 2128.32 (OR: 0.763, 95% CI: 0.603–0.967, p < 0.001), and FIB < 5.02 (OR: 2.287, 95% CI: 1.865–2.806, p < 0.001) were independent risk factors for active PTB. The specificity for ESAT-6 + CFP-10, ESAT-6 + CFP-10 + SII, ESAT-6 + CFP-10 + FIB, and ESAT-6 + CFP-10 + SII + FIB was 82.5%, 83.2%, 95.8%, and 80.1%, respectively, while sensitivity was 52.6%, 53.0%, 55.8%, and 44.7%, and positive predictive values were 85.0%, 85.6%, 84.1%, and 89.6%, respectively. Conclusion: SII and Fibrinogen are positively correlated with the degree of tuberculosis inflammation and the bacterial load of Mycobacterium tuberculosis . The combined detection of SII, Fibrinogen, and T-SPOT.TB is significant in distinguishing between active PTB with positive T-SPOT.TB results and non-tuberculous lung diseases.

Retrospective analysis of the clinical utility of multi-cytokine profiles in smear-negative pulmonary tuberculosis

The Diagnostic Efficiency Evaluation of Combination Tuberculosis Interferon-Gamma Release Assay with Human Leukocyte Antigen-G for Tuberculosis

Characterization of cytokine profile to distinguish latent tuberculosis from active tuberculosis and healthy controls.

Diagnostic Performance of Multiplex Cytokine and Chemokine Assay for Tuberculosis.

Multiplex Analysis of Plasma Cytokines/chemokines Showing Different Immune Responses in Active TB Patients, Latent TB Infection and Healthy Participants.

Cytokine and Antibody Based Diagnostic Algorithms for Sputum Culture-Positive Pulmonary Tuberculosis

Analysis Of Plasma Cytokine And Chemokine Profiles In Patients With And Without Tuberculosis By Liquid Array-Based Multiplexed Immunoassays

Antigen-specific chemokine profiles as biomarkers for detecting Mycobacterium tuberculosis infection

Multiple cytokine responses in discriminating between active tuberculosis and latent tuberculosis infection

Integrating systemic immune-inflammation index, fibrinogen, and T-SPOT.TB for precision distinction of active pulmonary tuberculosis in the era of mycobacterial disease research

Whole-blood culture-derived cytokine combinations for the diagnosis of tuberculosis

Profiling the human immune response to Mycobacterium tuberculosis by human cytokine array

Clinical Application of Interferon-Gamma Release Assays for Diagnosis of Pulmonary Tuberculosis and Extrapulmonary Tuberculosis

Specific Cytokines Analysis Incorporating Latency-Associated Antigens Differentiates Mycobacterium tuberculosis Infection Status: An Exploratory Study

Evaluation of the Diagnostic Potential of IP-10 and IL-2 As Biomarkers for the Diagnosis of Active and Latent Tuberculosis in a BCG-Vaccinated Population

The potential value of mtb-specific-antiqen induced factors as biomarkers for the differential diagnosis of active pulmonary tuberculosis

Screening and identification of a six-cytokine biosignature for detecting TB infection and discriminating active from latent TB

The meta-analysis for ideal cytokines to distinguish the latent and active TB infection

Serum Protein Profiling of Smear-Positive and Smear-Negative Pulmonary Tuberculosis Using SELDI-TOF Mass Spectrometry

IP-10 and MIG Are Compartmentalized at the Site of Disease During Pleural and Meningeal Tuberculosis and Are Decreased after Antituberculosis Treatment

Inadequate Values from an Interferon-Gamma Release Assay for Smear-Negative Tuberculosis in a High-Burden Setting.